Vitamin D and Subclinical Cerebrovascular Disease The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study

被引:44
作者
Michos, Erin D. [1 ,2 ]
Carson, Kathryn A. [2 ,3 ]
Schneider, Andrea L. C. [2 ]
Lutsey, Pamela L. [4 ]
Xing, Li [5 ]
Sharrett, A. Richey [2 ]
Alonso, Alvaro [4 ]
Coker, Laura H. [6 ]
Gross, Myron [4 ,7 ]
Post, Wendy [1 ,2 ]
Mosley, Thomas H. [8 ]
Gottesman, Rebecca F. [2 ,9 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21287 USA
[4] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[5] Univ British Columbia, Dept Stat, Vancouver, BC V5Z 1M9, Canada
[6] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA
[7] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[8] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS USA
[9] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
CARDIOVASCULAR-DISEASE; 25-HYDROXYVITAMIN D; INFARCTS; STROKE;
D O I
10.1001/jamaneurol.2014.755
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IMPORTANCE Vitamin D deficiency has been associated with hypertension, diabetes mellitus, and incident stroke. Little is known about the association between vitamin D and subclinical cerebrovascular disease. OBJECTIVE To examine the relationship of 25-hydroxyvitamin D (25[ OH] D) levels with cerebrovascular abnormalities as assessed on brain magnetic resonance imaging (MRI) among participants of the Atherosclerosis Risk in Communities (ARIC) Brain MRI study. DESIGN, SETTING, AND PARTICIPANTS Participants were white and black adults aged 55 to 72 years with no history of clinical stroke who underwent a cerebral MRI at ARIC visit 3 (n = 1622) and a second cerebral MRI approximately 10 years later (n = 888). EXPOSURES The 25(OH) D level was measured by mass spectrometry at visit 3, with levels adjusted for calendar month and categorized using race-specific quartiles. MAIN OUTCOMES AND MEASURES The cross-sectional and prospective associations of 25(OH) D levels with white matter hyperintensities (WMHs) and MRI-defined infarcts were investigated using multivariable regression models. RESULTS The mean age of the participants was 62 years, 59.6% were women, and 48.6% were black. Lower 25(OH) D levels were not significantly associated with WMH score of severity, prevalent high-grade WMH score (>= 3), or prevalent infarcts in cross-sectional, multivariable-adjusted models (all P > .05). Similarly, no significant prospective associations were found for lower 25(OH) D levels with change in WMH volume, incident high WMH score (>= 3), or incident infarcts on the follow-up MRI, which occurred approximately 10 years later. CONCLUSIONS AND RELEVANCE A single measure of 25(OH) D was not cross-sectionally associated with WMH grade or prevalent subclinical infarcts and was not prospectively associated with WMH progression or subclinical brain infarcts seen on serial cerebral MRIs obtained approximately 10 years apart. These findings do not support optimizing vitamin D levels for brain health.
引用
收藏
页码:863 / 871
页数:9
相关论文
共 23 条
[1]   Vitamin D and cognitive performance in adults: a systematic review [J].
Annweiler, C. ;
Allali, G. ;
Allain, P. ;
Bridenbaugh, S. ;
Schott, A. -M. ;
Kressig, R. W. ;
Beauchet, O. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (10) :1083-1089
[2]  
Annweiler Cedric, 2012, Open Neuroimag J, V6, P16, DOI 10.2174/1874440001206010016
[3]  
BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
[4]   CEREBRAL WHITE-MATTER LESIONS, VASCULAR RISK-FACTORS, AND COGNITIVE FUNCTION IN A POPULATION-BASED STUDY - THE ROTTERDAM STUDY [J].
BRETELER, MMB ;
VANSWIETEN, JC ;
BOTS, ML ;
GROBBEE, DE ;
CLAUS, JJ ;
VANDENHOUT, JHW ;
VANHARSKAMP, F ;
TANGHE, HLJ ;
DEJONG, PTVM ;
VANGIJN, J ;
HOFMAN, A .
NEUROLOGY, 1994, 44 (07) :1246-1252
[5]   25-Hydroxyvitamin D and Symptomatic Ischemic Stroke: An Original Study and Meta-Analysis [J].
Brondum-Jacobsen, Peter ;
Nordestgaard, Borge G. ;
Schnohr, Peter ;
Benn, Marianne .
ANNALS OF NEUROLOGY, 2013, 73 (01) :38-47
[6]   25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services [J].
Buell, J. S. ;
Dawson-Hughes, B. ;
Scott, T. M. ;
Weiner, D. E. ;
Dallal, G. E. ;
Qui, W. Q. ;
Bergethon, P. ;
Rosenberg, I. H. ;
Folstein, M. F. ;
Patz, S. ;
Bhadelia, R. A. ;
Tucker, K. L. .
NEUROLOGY, 2010, 74 (01) :18-26
[7]   Vitamin D and neurocognitive dysfunction: Preventing "D"ecline? [J].
Buell, Jennifer S. ;
Dawson-Hughes, Bess .
MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (06) :415-422
[8]   Plasma 25-hydroxyvitamin D levels and risk of incident hypertension [J].
Forman, John P. ;
Giovannucci, Edward ;
Holmes, Michelle D. ;
Bischoff-Ferrari, Heike A. ;
Tworoger, Shelley S. ;
Willett, Walter C. ;
Curhan, Gary C. .
HYPERTENSION, 2007, 49 (05) :1063-1069
[9]   Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort Atherosclerosis Risk in Communities (ARIC) Study [J].
Gottesman, Rebecca F. ;
Coresh, Josef ;
Catellier, Diane J. ;
Sharrett, A. Richey ;
Rose, Kathryn M. ;
Coker, Laura H. ;
Shibata, Dean K. ;
Knopman, David S. ;
Jack, Clifford R. ;
Mosley, Thomas H., Jr. .
STROKE, 2010, 41 (01) :3-8
[10]   Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs [J].
Hollis, Bruce W. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2008, 88 (02) :507S-510S